Passage BIO, Inc.
PASG · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Lynx1 Capital Management LP: Form 4
Insider disclosure · Filed · Report period 25 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001787297 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PASG on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- One Commerce Square, 2005 Market Street, 39 Th Floor, Philadelphia, PA, 19103
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields